Next we hypothesized that high expression of PAX6 might be generalized in other neuroendocrine cancers, and we examined expression of PAX6 in SCLC that is also a type of neuroendocrine and compared it to non-small cell lung cancer (NSCLC). This evidence concerns the gene PAX6 and neuroendocrine carcinoma.